Navigation Links
Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
Date:12/13/2007

foundation of breast cancer chemotherapy for more than 30 years.

"The investigational Taxotere(R) combination significantly increased the percentage of women living with no signs of cancer at seven years, as compared to the anthracycline combination," said Dr. Jones.

US Oncology Adjuvant Trial 9735 Protocol

USO Adjuvant Trial 9735 was designed primarily to evaluate disease-free survival among women with node-positive and node-negative early breast cancer. Node-positive indicates that the cancer has spread to the lymph nodes under the arm, while node-negative breast cancer means that the lymph nodes are clear of cancer. Secondary endpoints included overall survival and safety. The investigators also explored the efficacy and safety of the treatments based on the age of patients and the biologic characteristics of their tumors.

All patients taking part in the study had received surgery for Stage I-III invasive breast cancer, meaning that the cancer was either localized to the breast or had spread to the lymph nodes under the adjacent arm.

A total of 1016 patients were randomized between June 1997 and December 1999; 48% of patients had node-negative disease and 16% were age 65 years or older. After surgery, patients were randomized to receive four cycles of either standard-dose of anthracycline doxorubicin 60 mg/m2 and cyclophosphamide 600/mg/m2 (n=510) or Taxotere(R) 75 mg/m2 and cyclophosphamide 600mg/m2 (n=506), administered by intravenous infusion every three weeks. After chemotherapy was completed, patients were treated with radiation therapy if indicated. Patients with hormone receptor positive disease also received hormonal therapy (tamoxifen).

In the TC group, there were 88 DFS events (17%) and 58 deaths (12%). The AC group had 118 DFS events (23%) and 84 deaths (17%). Exploratory analyses showed benefit of TC irrespective of age, hormonal status or Her2 status.

Grade 3-4 neutropenia occurred in 60% of younger (<
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
2. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
3. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
4. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
5. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
6. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
7. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
8. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
9. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
10. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
11. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The FBI recently approved the Promega Pow...ipating in or generating DNA records for the Natio...adison, WI USA (PRWEB) -- The FBI recently approve...e by laboratories participating in, or generating ...IS). NDIS currently contains more than seven milli...
(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,...lcompany,today,announcedthatithassubmittedaMAAtoth...ompany,senzymereplacementtherapyindevelopment,fort...keting,applicationforvelaglucerasealfathathasbeens...andCanada. , Basedonaglobalsupplyshortageofth...
(Date:11/24/2009)...ly,November24/PRNewswire/--HealthRoboticstodayanno...groupofselected,investors.ThisrecentlyformedToront...csCanada,Inc.andwillmarket,install,andsupport,Heal...sthe,revolutionaryproductofferingsi.v.STATION(TM),...illalsoprovideassistanceonan"asneeded,basis"toitss...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--CellTherapeutics,Inc....21stAnnualPiperJaffrayHealthCareConference.Theconf...eHotel. ,, CTIwillpresentonTuesday,December1at1...ebcastofCTI,spresentationwillbeavailableat www.cel...ayafterwards. , ,PiperJaffrayHealthCareConference...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...ong Commitment to Ethical Information Exchange b...gy and Pharmaceutical Compan... announced,today that the company has adopted and ... PhRMA Code on Interactions with Healthcare Profes...on the prior 2002 version, was,approved unanimousl...
...thene, Inc.,(Amex: PIP ) a biodefense company spe... of medical countermeasures against chemical and,b...Karp, J.D., has been,appointed Senior Vice Preside...an resources matters for PharmAthene., Mr. Karp j...ience in a,variety of areas, including SEC complia...
... access to 'Best Practices for Long-term Jatr... R. Rajagopal's highly successful November 20...stock: Jatropha: A Strategic Option', is bein...inability criterion for Jatropha as it nears comme.... Key points outlined in Dr. R. Rajagopal's l...
Other Biology Technology:EMD Serono to Adopt Revised and Strengthened PhRMA Code 2EMD Serono to Adopt Revised and Strengthened PhRMA Code 3EMD Serono to Adopt Revised and Strengthened PhRMA Code 4PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel 2PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel 3Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 2Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 3Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy 4
(Date:11/23/2009)..., CHAMPAIGN, Ill. A new study provides "incont...ion of Toba on the island of Sumatra about 73,000 ...,000 miles from the epicenter, researchers report....lometers of ash into the atmosphere, leaving a cra...s 100 kilometers long and 35 kilometers wide. Ash ...
(Date:11/23/2009)..., DURHAM, N.H. University of New Hampshire mic...aling $498,115 to advance understanding of the act...ential to enrich nutrient-poor and contaminated so...ure (USDA) awarded Tisa, a professor of molecular,...lore the symbiotic relationship between the bacter...
(Date:11/23/2009)..., , , , , , , , , , ... , , AUDIO: , Dr Andrew Mar...ersity of York, discusses the discovery of Kinyon... , Click here for more information... , , , , , , , ...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510 28k 29 Market Clearance as a Lumbar Intervertebral Body Fusion Device 55484 1Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510 28k 29 Market Clearance as a Lumbar Intervertebral Body Fusion Device 55484 2Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510 28k 29 Market Clearance as a Lumbar Intervertebral Body Fusion Device 55484 3LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3
... -- Growing recognition of the importance of healt... and societal change has prompted the Proceedings ...a new subsection in Sustainable Health to its exis...ural subsection, posted online Oct. 3, 2007 includ...vard School of Public Health (HSPH), describing th...
... Sensitive skin . . . , People with tomorrow,s ...t, cold and touch through a series of developments...nd NASA. Two different ORNL research groups, Ilia ...s Synthesis and Properties Group, and John Simpson...ining superhydrophobic material with thin layers o...
... -- If projected increases in the use of corn for ...y could be considerable, and water supply problems..., says a new report from the National Research Cou...d policy options and identified opportunities for ...lp minimize effects of biofuel production on water...
Other Biology News:Data on life expectancy show many countries clustered in high mortality traps 2Data on life expectancy show many countries clustered in high mortality traps 3Story tips from the Department of Energy's Oak Ridge National Laboratory, October 2007 2Increase in ethanol production from corn could significantly impact 2Increase in ethanol production from corn could significantly impact 3
...ns Protein 295 ex can measure three fluorescence l...e in only a few minutes. To match the absorption m...the Protein 295 exs excitation source is the power...uorescence of tryptophan is widely used as a probe...
... cDNA Library Panels were designed for full-length...to identify the desired cDNA clone. The first PCR ... where each well contains plasmid DNA from 5,000 c...el electrophoresis of the reaction products, the s...
... cDNA Library Panels were designed for full-length...to identify the desired cDNA clone. The first PCR ... where each well contains plasmid DNA from 5,000 c...el electrophoresis of the reaction products, the s...
...measuring instrument for calibrating single-channe...act design and the robust carrying case, the MCP1-...boratory and on-site at the users premises. The un... channels are tested automatically. Multi-channel ...
Biology Products: